Cost Utility Analysis in Recurrent Ovarian Cancer

Withdrawn before enrolling

Conditions studied: Ovarian Cancer

In brief

The goal of this research study is to learn about the quality of life and sexual functioning of women with platinum-resistant ovarian cancer as they receive other treatments for the disease. Researchers will study the costs for chemotherapy treatments, other medical expenses, and treatment-related expenses that are not medical. Researchers will also review any symptoms these patients may experience related to the cancer or treatment. In addition, researchers want to learn if and how these patients' caregivers feel the status of these patients' health may have affected the caregivers' productivity at work and at home.

Key facts

Study ID

NCT00813254

Run by

M.D. Anderson Cancer Center

People needed

0

Starts

2008-12-01

Expected to finish

2011-01-01

Last updated by the study team

2012-04-19

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients with recurrent, platinum-resistant epithelial ovarian cancer who are beginning any second-line treatment
• Patients must be English-speaking
• Patients must be able to read and write English
• Patients receiving all chemotherapy at MD Anderson Cancer Center

You may not qualify if…

• Patients with non-epithelial ovarian cancers including sex-cord stromal tumors, germ cell tumors, low-grade tumors, and metastatic disease to the ovary
• Patients who are receiving protocol therapy
• Patients who have had a prior diagnosis of invasive cancer at other sites (excluding basal cell carcinoma of the skin)
• Patients who are receiving radiation therapy as a treatment modality

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.